F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,568 | 52,963 | 68,801 | 78,549 | 71,050 |
| Receivables | 8,145 | 7,074 | 4,167 | 2,311 | 1,938 |
| TOTAL | $49,609 | $64,862 | $77,286 | $84,739 | $76,161 |
| Non-Current Assets | |||||
| PPE Net | 879 | 813 | 743 | 887 | 1,011 |
| Intangibles | 14,117 | 14,451 | 14,772 | 14,898 | 14,885 |
| Other Non-Current Assets | 19,112 | 20,518 | 21,905 | 22,497 | 22,741 |
| TOTAL | $34,108 | $35,782 | $37,420 | $38,282 | $38,637 |
| Total Assets | $83,717 | $100,644 | $114,706 | $123,021 | $114,798 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,315 | 353 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,501 | 4,048 | 4,310 | 3,081 | 1,569 |
| Accrued Expenses | 7,747 | 8,314 | 5,511 | 6,241 | 5,642 |
| Other current liabilities | 2,286 | 1,740 | 1,936 | 1,907 | 648 |
| TOTAL | $14,675 | $15,317 | $12,653 | $12,135 | $8,835 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,525 | 9,398 | 9,675 | 9,605 | 9,535 |
| Other Non-Current Liabilities | 3,572 | 2,046 | 1,723 | 4,417 | 2,899 |
| TOTAL | $12,104 | $13,690 | $13,889 | $14,029 | $15,885 |
| Total Liabilities | $26,779 | $29,007 | $26,542 | $26,164 | $24,720 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,982 | 21,585 | 21,493 | 21,065 | 20,624 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -127,939 | -109,532 | -90,538 | -78,451 | -83,192 |
| Other shareholders' equity | 1,565 | -692 | -1,441 | -1,502 | -1,142 |
| TOTAL | $56,938 | $71,637 | $88,164 | $96,857 | $90,078 |
| Total Liabilities And Equity | $83,717 | $100,644 | $114,706 | $123,021 | $114,798 |